ZVRA
Zevra Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$9.98
-0.21 ▼ -2.01%
🌙 3월 13일 7:37 PM ET (한국 3/14 08:37)
$9.96
-0.02 ▼ -0.20%
| Index | RUT | P/E | 6.68 | EPS (ttm) | 1.49 | Insider Own | 1.37% | Shs Outstand | 0.06B | Perf Week | 11.14% |
| Market Cap | 0.59B | Forward P/E | 6.91 | EPS next Y | 214.13% | Insider Trans | -13.84% | Shs Float | 0.06B | Perf Month | 17.69% |
| Enterprise Value | 0.46B | PEG | 0.33 | EPS next Q | 0.07 | Inst Own | 65.38% | Short Float | 9.35% | Perf Quarter | 18.11% |
| Income | 0.08B | P/S | 5.5 | EPS this Y | -65.93% | Inst Trans | -3.06% | Short Ratio | 4.91 | Perf Half Y | 25.53% |
| Sales | 0.11B | P/B | 3.67 | EPS next 5Y | 20.75% | ROA | 35.82% | Short Interest | 5.41M | Perf YTD | 11.38% |
| Book/sh | 2.72 | P/C | 3.07 | EPS past 3/5Y | - | ROE | 85.32% | 52W High | -24.16% ($13.16) | Perf Year | 25.69% |
| Cash/sh | 3.25 | P/FCF | - | Sales past 3/5Y | 118.82% 51.62% | ROIC | 38.12% | 52W Low | 61.23% ($6.19) | Perf 3Y | 124.77% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 167.35% | Gross Margin | 80.85% | Volatility(W/M) | 7.61% 4.88% | Perf 5Y | 6.28% |
| Dividend TTM | - | EV/Sales | 4.3 | Sales Y/Y TTM | 350.91% | Oper. Margin | -3.98% | ATR (14) | 0.6 | Perf 10Y | -95.56% |
| Dividend Ex-Date | - | Quick Ratio | 5.63 | EPS Q/Q | 129.57% | Profit Margin | 77.86% | RSI (14) | 59.71 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.68 | Sales Q/Q | 183.36% | SMA20 | 8.77% ($9.18) | Beta | 0.88 | Target Price | $22.75 |
| Payout | - | Debt/Eq | 0.41 | Earnings | 3000000 | SMA50 | 11.76% ($8.93) | Rel Volume | 0.95 | Prev Close | $10.19 |
| Employees | 61 | LT Debt/Eq | 0.41 | EPS/Sales Surpr. | 276.98% 21.56% | SMA200 | 5.51% ($9.46) | Avg Volume(3M) | 1.10M | Price | $9.98 |
| IPO | 2015/4/16 | Option/Short | Yes/Yes | Trades | 11734 | Volume | 1,050,592 | Change | -2.01% |
뉴스 로딩 중...